These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33462138)

  • 1. The Phosphoenolpyruvate Carboxykinase Is a Key Metabolic Enzyme and Critical Virulence Factor of
    Barazandeh AF; Mou Z; Ikeogu N; Mejia EM; Edechi CA; Zhang WW; Alizadeh J; Hatch GM; Ghavami S; Matlashewski G; Marshall AJ; Uzonna JE
    J Immunol; 2021 Mar; 206(5):1013-1026. PubMed ID: 33462138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.
    Lang T; Courret N; Colle JH; Milon G; Antoine JC
    Infect Immun; 2003 May; 71(5):2674-83. PubMed ID: 12704142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.
    Holowka T; Castilho TM; Garcia AB; Sun T; McMahon-Pratt D; Bucala R
    FASEB J; 2016 Jun; 30(6):2249-65. PubMed ID: 26956417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
    Gumy A; Aseffa A; Rachinel N; Breton M; Otten L; Tacchini-Cottier F; Röcken M; Doyen N; Acha-Orbea H; Locksley RM; MacDonald HR; Launois P; Louis J
    Eur J Immunol; 2006 Jun; 36(6):1465-73. PubMed ID: 16637008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody.
    Colmenares M; Constant SL; Kima PE; McMahon-Pratt D
    Infect Immun; 2002 Dec; 70(12):6597-605. PubMed ID: 12438331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
    Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR
    Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice.
    Davenport BJ; Martin CG; Beverley SM; Orlicky DJ; Vazquez-Torres A; Morrison TE
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006921. PubMed ID: 30372439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
    Reiner SL; Zheng S; Wang ZE; Stowring L; Locksley RM
    J Exp Med; 1994 Feb; 179(2):447-56. PubMed ID: 7905017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
    Courret N; Lang T; Milon G; Antoine JC
    Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major.
    Daneshvar H; Burchmore R; Hagan P; Phillips RS
    Parasitology; 2009 Sep; 136(11):1243-50. PubMed ID: 19646303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge.
    Ramírez L; Iborra S; Cortés J; Bonay P; Alonso C; Barral-Netto M; Soto M
    J Biomed Biotechnol; 2010; 2010():181690. PubMed ID: 20145701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.
    Belkaid Y; Mendez S; Lira R; Kadambi N; Milon G; Sacks D
    J Immunol; 2000 Jul; 165(2):969-77. PubMed ID: 10878373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania major parasite stage-dependent host cell invasion and immune evasion.
    Wenzel UA; Bank E; Florian C; Förster S; Zimara N; Steinacker J; Klinger M; Reiling N; Ritter U; van Zandbergen G
    FASEB J; 2012 Jan; 26(1):29-39. PubMed ID: 21908716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Protective
    Mou Z; Barazandeh AF; Hamana H; Kishi H; Zhang X; Jia P; Ikeogu N; Onyilagha C; Gupta G; Uzonna JE
    J Immunol; 2020 Sep; 205(5):1355-1364. PubMed ID: 32727889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell hypo-responsiveness against Leishmania major in MAP kinase phosphatase (MKP) 2 deficient C57BL/6 mice does not alter the healer disease phenotype.
    Schroeder J; McGachy HA; Woods S; Plevin R; Alexander J
    PLoS Negl Trop Dis; 2013; 7(2):e2064. PubMed ID: 23437409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.